The connection between CVD and diabetes cannot be understated, as diabetes impacts CV health and heart conditions affect ...

Results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in overweight patients with cardiovascular disease.

A study has found that aficamten is associated with improvements across a range of clinical outcomes in patients with obstructive hypertrophic cardiomyopathy.

The cardiometabolic index was significantly associated with a higher risk for endometriosis, especially at a value exceeding 0.67.

Vegan vs omnivore diet was associated with greater weight loss and improved lipid profiles at 6 and 24 months among Black adults.

Patients with sarcoidosis treated with ACE inhibitors had greater mortality risk than those treated with angiotensin receptor blockers.

Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.

TTVR plus optimal medical therapy yields greater improvement in disease-specific and general health status than OMT alone. HealthDay News — For patients with symptomatic and severe or greater ...

Risk for heart failure events is decreased and health status is improved in patients with HFmrEF and HFpEF receiving finerenone.

Topline results were announced from a cardiovascular outcomes study evaluating oral semaglutide in patients with type 2 diabetes.

Late morning eating time was associated with a lower risk for cardiovascular disease mortality among individuals with type 2 diabetes.

Stroke burden and the contribution of several risk factors have increased from 1990 to 2021 on the global, regional, and national level.